CYP3A4 and myopathy: In Latin American populations, Alvarado et al. [247] emphasized that individuals harboring both CYP3A4 and SLCO1B1 risk alleles have a markedly higher susceptibility to simvastatin- and atorvastatin-induced myopathy and intolerance.